Patent ID: 6391339
Filing Date: 2002-05-21
Classification: A61K,A61P,Y10S

Abstract:
A method for preventing clotting in an extracorporeal blood circuit of a patient undergoing extracorporeal blood treatment comprising, administering 0.001 to 10 mg of a decasodium salt of methyl Oâ€”(2-deoxy-2-sulphoamino-6-O-sulpho-&agr;-D-glucopyranosyl)-(1â†’4)â€”Oâ€”(&bgr;D-glucopyranosyl uronic acid)-(1â†’4)â€”Oâ€”(2-deoxy-2-sulphoamino-3,6-di-O-sulpho-&agr;-D-glucopyranosyl)-(1â†’4)â€”Oâ€”(2-O-sulpho-&agr;-L-idopyranosyl uronic acid)-(1â†’4)-2-deoxy-2-sulphoamino-6-O-sulpho-&agr;-D-glucopyranoside per kg body weight of the patient.